Our Research Grants

Children with high risk cancers often have few options for treatment, and the chemotherapies they receive tend to bombard their systems with toxins rather than targeting specific cells or molecular pathways.  We provide research grants that help scientists take innovative approaches to finding safer treatments and offering kids better odds for survival.  You can click on the links below to read more about the projects we have funded. We think Jake would be pleased with the punches we’ve landed for all the kids who today continue to fight cancer.

We continue in the spirit of “Don’t let the cancer win!”

2016 Research Grants

Development of Pharmacologic Agents to Target Leukemic Stem Cells, conducted by Dr. Tomasz Cierpicki at the University of Michigan. Funded in partnership with the Leukemia & Lymphoma Society.

2015 Research Grant

Characterization of CD99 as a Therapeutic Target in MDS and AML, conducted by Dr. Stephen Chung at the Memorial Sloan Kettering Cancer Center. Funded in partnership with the American Society of Hematology.

2014 Research Grant

Targeting CD123 using Chimeric Antigen Receptor T Cells for Treatment of Acute Myeloid Leukemia, conducted by Dr. Lihua Elizabeth Budde at the City of Hope Hospital. Funded in partnership with the Damon Runyon Cancer Research Foundation.

2013 Research Grants

Engineered T Cells against WT1 for Treatment of Acute Myeloid Leukemia, conducted by Dr. Sarwish Rafiq at the Sloan Kettering Institute for Cancer Research. Funded in partnership with the Leukemia & Lymphoma Society.

Controlling Cell Differentiation Through Modular Assembly of Cell-permeable Transcription Regulating Proteins, conducted by Dr. Rahul Palchaudhuri at Harvard University. Funded in partnership with the Life Sciences Research Foundation.

2012 Research Grants

Targeting BCL6 in acute myeloid leukemia (AML) stem cells, conducted by Dr. Cihangir Duy at the Weill Cornell Medical College.  Funded in partnership with the Leukemia & Lymphoma Society.

Identification and characterization of novel ribosome-associated proteins and their role in hematopoietic development and disease, conducted by Dr. Anne Bothmer at the Beth Israel Deaconess Medical Center, Harvard Medical School.  Funded in partnership with the Damon Runyon Cancer Research Foundation.

2011 Research Grant

Antibody Conjugates for Targeted AML Therapy, conducted by Dr. Hua Lu at the Scripps Research Institute.  Funded in partnership with the Damon Runyon Cancer Research Foundation.